FDA Approves Genetic Test for Breast Cancer (HealthDay)
Font size:
HealthDay - TUESDAY, July 8 (HealthDay News) -- A genetic test to determine
whether a breast cancer patient is likely to respond to treatment with the
drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug
Administration.
Add to:
del.icio.us |
Digg
del.icio.us |
Digg
Email to a friend
Print version
Plain textRate this article
Comments (0 posted):
Post your comment